Catheter-Directed Therapy for Acute Submassive Pulmonary Embolism: Summary of Current Evidence and Protocols

Tech Vasc Interv Radiol. 2017 Sep;20(3):193-196. doi: 10.1053/j.tvir.2017.07.009. Epub 2017 Jul 8.

Abstract

Treatment of acute submassive pulmonary embolism (PE) with thrombolytic therapy remains an area of controversy. For patients who fail or who have contraindications to systemic thrombolysis, catheter-directed therapy (CDT) may be offered depending on the patient's condition and the available institutional resources to perform CDT. Although various CDT techniques and protocols exist, the most studied method is low-dose catheter-directed thrombolytic infusion without mechanical thrombectomy. This article reviews current protocols and data on the use of CDT for acute submassive pulmonary embolism.

Keywords: Catheter; Pulmonary Embolism; Submassive PE; Thrombolysis.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Catheterization, Swan-Ganz / adverse effects
  • Catheterization, Swan-Ganz / instrumentation*
  • Catheters*
  • Clinical Protocols*
  • Equipment Design
  • Evidence-Based Medicine*
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Infusions, Intra-Arterial
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / physiopathology
  • Risk Factors
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / instrumentation*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents